On 11 February 2020 the test was registered by the Federal Service for Surveillance in Healthcare.On 12 March 2020, Mayo Clinic was reported to have developed a test to detect COVID-19 infection.On 13 March 2020, Roche Diagnostics received FDA approval for a test which could be performed within 3.5 hours in high volume, thus allowing one machine to do approximately 4,128 tests in a 24-hour period.